Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival
Summary. Background: The malignant melanoma (MM) incidence rates were increasing and later stabilizing in many regions of the world, while in South-Eastern Europe incidence rates are uniformly increasing and mortality rates are higher. Aim: To describe burden of MM in Ukraine in terms of incidence,...
Saved in:
| Date: | 2023 |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
PH Akademperiodyka
2023
|
| Subjects: | |
| Online Access: | https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Experimental Oncology |
Institution
Experimental Oncology| id |
oai:ojs2.ex.aqua-time.com.ua:article-152 |
|---|---|
| record_format |
ojs |
| institution |
Experimental Oncology |
| baseUrl_str |
|
| datestamp_date |
2023-10-11T16:43:48Z |
| collection |
OJS |
| language |
English |
| topic |
cancer registry incidence malignant melanoma mortality stage survival |
| spellingShingle |
cancer registry incidence malignant melanoma mortality stage survival Korovin, S. Fedorenko, Z. Michailovich, Yu. Kukushkina, M. Sekerija, M. Ryzhov, A. Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival |
| topic_facet |
cancer registry incidence malignant melanoma mortality stage survival cancer registry incidence malignant melanoma mortality stage survival |
| format |
Article |
| author |
Korovin, S. Fedorenko, Z. Michailovich, Yu. Kukushkina, M. Sekerija, M. Ryzhov, A. |
| author_facet |
Korovin, S. Fedorenko, Z. Michailovich, Yu. Kukushkina, M. Sekerija, M. Ryzhov, A. |
| author_sort |
Korovin, S. |
| title |
Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival |
| title_short |
Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival |
| title_full |
Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival |
| title_fullStr |
Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival |
| title_full_unstemmed |
Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival |
| title_sort |
burden of malignant melanoma in ukraine in 2002–2013: incidence, mortality and survival |
| title_alt |
Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival |
| description |
Summary. Background: The malignant melanoma (MM) incidence rates were increasing and later stabilizing in many regions of the world, while in South-Eastern Europe incidence rates are uniformly increasing and mortality rates are higher. Aim: To describe burden of MM in Ukraine in terms of incidence, mortality and survival by sex, age and stage for the period 2002–2013 and compare with European countries. Materials and Methods: Database of the National Cancer Registry of Ukraine was used to extract MM incidence cases; number of MM deaths was obtained from the official mortality statistics. Age-standardised and age-specific incidence and mortality rates were calculated by sex, age groups (15–39, 40–59 and 60+); estimated annual percent of change was used to describe trends. Proportions of new cases by stage of disease and calendar period (2002–2007 vs 2008–2013) were compared as well as net survival estimates. Results: In Ukraine, MM was more common in females (age-standardised 5.3 per 100,000 in 2013; annual percent of change 3.5%) than in males (5.1 per 100,000; 4.1%); around 50% of them diagnosed in the age group 60+. The observed increase in proportion of new cases with early stage (I–II) was due to stage II cases. The slight increase in mortality rates in males or stability in females were not accompanied with increase of survival. Net MM survival was consistently lower comparing to European countries. Conclusion: More resources should be targeted to increase the capacity of healthcare in diagnostics and treatment of malignant melanoma, but also in promoting healthcare and education in Ukraine. |
| publisher |
PH Akademperiodyka |
| publishDate |
2023 |
| url |
https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-7 |
| work_keys_str_mv |
AT korovins burdenofmalignantmelanomainukrainein20022013incidencemortalityandsurvival AT fedorenkoz burdenofmalignantmelanomainukrainein20022013incidencemortalityandsurvival AT michailovichyu burdenofmalignantmelanomainukrainein20022013incidencemortalityandsurvival AT kukushkinam burdenofmalignantmelanomainukrainein20022013incidencemortalityandsurvival AT sekerijam burdenofmalignantmelanomainukrainein20022013incidencemortalityandsurvival AT ryzhova burdenofmalignantmelanomainukrainein20022013incidencemortalityandsurvival |
| first_indexed |
2025-07-17T12:15:52Z |
| last_indexed |
2025-07-17T12:15:52Z |
| _version_ |
1850411020717129728 |
| spelling |
oai:ojs2.ex.aqua-time.com.ua:article-1522023-10-11T16:43:48Z Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival Burden of malignant melanoma in Ukraine in 2002–2013: incidence, mortality and survival Korovin, S. Fedorenko, Z. Michailovich, Yu. Kukushkina, M. Sekerija, M. Ryzhov, A. cancer registry, incidence, malignant melanoma, mortality, stage, survival cancer registry, incidence, malignant melanoma, mortality, stage, survival Summary. Background: The malignant melanoma (MM) incidence rates were increasing and later stabilizing in many regions of the world, while in South-Eastern Europe incidence rates are uniformly increasing and mortality rates are higher. Aim: To describe burden of MM in Ukraine in terms of incidence, mortality and survival by sex, age and stage for the period 2002–2013 and compare with European countries. Materials and Methods: Database of the National Cancer Registry of Ukraine was used to extract MM incidence cases; number of MM deaths was obtained from the official mortality statistics. Age-standardised and age-specific incidence and mortality rates were calculated by sex, age groups (15–39, 40–59 and 60+); estimated annual percent of change was used to describe trends. Proportions of new cases by stage of disease and calendar period (2002–2007 vs 2008–2013) were compared as well as net survival estimates. Results: In Ukraine, MM was more common in females (age-standardised 5.3 per 100,000 in 2013; annual percent of change 3.5%) than in males (5.1 per 100,000; 4.1%); around 50% of them diagnosed in the age group 60+. The observed increase in proportion of new cases with early stage (I–II) was due to stage II cases. The slight increase in mortality rates in males or stability in females were not accompanied with increase of survival. Net MM survival was consistently lower comparing to European countries. Conclusion: More resources should be targeted to increase the capacity of healthcare in diagnostics and treatment of malignant melanoma, but also in promoting healthcare and education in Ukraine. Summary. Background: The malignant melanoma (MM) incidence rates were increasing and later stabilizing in many regions of the world, while in South-Eastern Europe incidence rates are uniformly increasing and mortality rates are higher. Aim: To describe burden of MM in Ukraine in terms of incidence, mortality and survival by sex, age and stage for the period 2002–2013 and compare with European countries. Materials and Methods: Database of the National Cancer Registry of Ukraine was used to extract MM incidence cases; number of MM deaths was obtained from the official mortality statistics. Age-standardised and age-specific incidence and mortality rates were calculated by sex, age groups (15–39, 40–59 and 60+); estimated annual percent of change was used to describe trends. Proportions of new cases by stage of disease and calendar period (2002–2007 vs 2008–2013) were compared as well as net survival estimates. Results: In Ukraine, MM was more common in females (age-standardised 5.3 per 100,000 in 2013; annual percent of change 3.5%) than in males (5.1 per 100,000; 4.1%); around 50% of them diagnosed in the age group 60+. The observed increase in proportion of new cases with early stage (I–II) was due to stage II cases. The slight increase in mortality rates in males or stability in females were not accompanied with increase of survival. Net MM survival was consistently lower comparing to European countries. Conclusion: More resources should be targeted to increase the capacity of healthcare in diagnostics and treatment of malignant melanoma, but also in promoting healthcare and education in Ukraine. PH Akademperiodyka 2023-05-30 Article Article application/pdf https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-7 10.32471/exp-oncology.2312-8852.vol-42-no-4.15334 Experimental Oncology; Vol. 42 No. 4 (2020): Experimental Oncology; 324-329 Експериментальна онкологія; Том 42 № 4 (2020): Експериментальна онкологія; 324-329 2312-8852 1812-9269 10.32471/exp-oncology.2312-8852.vol-42-no-4 en https://exp-oncology.com.ua/index.php/Exp/article/view/2020-4-7/2020-4-7 Copyright (c) 2023 Experimental Oncology https://creativecommons.org/licenses/by-nc/4.0/ |